Investors — Valens GroWorks Corp.

Stock Information

VGW

$1.11 Today’s price

-0.02 24-hour Change ($)

-1.77% 24-hour Change (%)

121350 24-hour Volume

Press Releases

VALENS GROWORKS ANNOUNCES AGM, CORPORATE DEVELOPMENTS - Kelowna, B.C., August 3, 2018 – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licensed, vertically integrated provider of cannabis products and services utilizing proprietary extraction processes, is…

Valens GroWorks Finalizes Greenhouse Expansion Plans - Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multilicensed, vertically integrated provider of cannabis products and services utilizing proprietary extraction processes, is pleased to provide an update on…

Valens GroWorks Announces ISO 17025 Accreditation - Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licensed vertically integrated provider of cannabis products and services utilizing proprietary extraction processes, is pleased to announce that its wholly-owned…

View All

This is Valens

Poised for Success

The medical and recreational cannabis markets are estimated to be worth a combined $23 billion annually.

Ready to Grow

Our cultivation facilities are operational and configured to expand pending our Licensed Producer approval. Phase one revenue is estimated in excess of $7M. Phase 2 construction is scheduled to begin after LP approval.

A Path to Revenue

Our industry-first approval allows the production of 100% cannabis oil for immediate sale through our supply agreement with Canopy Growth. That provides VGW with immediate revenue that stands to increase significantly with October’s pending recreational legalization.

Sales on the Rise

Medical Cannabis users in Canada are forecast to increase from 200,000 today to over 700,000 by 2020. The recreational market is expected to exceed $20B annually. Sales of cannabis oil have increased over 300% in the past year.